The Louisiana Cancer Endowment (LCE) is proud to recognize Pfizer and AstraZeneca as Gold-level partners, reflecting their strong commitment to advancing cancer care, research, education, and health equity in Louisiana. Through generous financial sponsorship and ongoing engagement, these leading biopharmaceutical companies are helping LCE expand its ability to convene experts, support innovative initiatives, and address the challenges that impact cancer patients and communities across the state.
Pfizer has played a particularly significant role in supporting LCE’s statewide efforts to improve prostate and bladder cancer care. Through two major initiatives, Pfizer and LCE have worked with physicians, health systems, and cancer care leaders across Louisiana to identify geographic and practice-level disparities in cancer care and better understand barriers to guideline-adherent treatment. These collaborations have helped translate real-world findings into practical solutions, including changes in referral patterns and approaches to care within major health systems across the state.
LCE is grateful for the leadership and support of both Pfizer and AstraZeneca as Gold-level partners. Their commitment demonstrates the potential of strong industry–nonprofit collaboration to generate meaningful insights, strengthen cancer care, and ultimately improve outcomes for patients throughout Louisiana.
PARTNERSHIP OPPORTUNITIES
The Louisiana Cancer Endowment (LCE) is actively seeking to expand its network of industry partners committed to advancing cancer research, education, innovation, and patient care across Louisiana. Through multi-year partnerships, companies and organizations can align with LCE at the Bronze, Silver, or Gold level, providing financial support while also engaging in meaningful collaboration with the Endowment and the broader cancer community.
These partnerships are designed to be more than traditional sponsorships. Industry partners have opportunities to share expertise, participate in strategic discussions, and help inform areas of focus that can strengthen cancer care and research across the state. Gold-level partners may have additional opportunities to collaborate on special projects and research programs and may host workshops at the annual CAGLA conference, connecting their expertise and resources with physicians, researchers, healthcare leaders, and other stakeholders.
LCE welcomes companies and organizations that share its commitment to improving cancer outcomes and reducing disparities to explore partnership opportunities. By working together over multiple years, industry and nonprofit leaders can help accelerate innovation, support meaningful research and education, and create lasting impact for patients and communities throughout Louisiana.